About
Laronix is a medical technology and biotechnology company that develops non-invasive voice solutions for individuals experiencing permanent or severe voice loss, such as throat cancer survivors and laryngectomy patients. Established around 2020, Laronix has built on over a decade of research to create innovative products that restore natural-sounding voices using advanced software and artificial intelligence. The company's flagship product, AVA Voice, is a pioneering bionic voice box that offers a non-invasive alternative to traditional artificial voice boxes. AVA Voice uses AI to replicate the wearer’s natural voice, enhancing communication and improving the quality of life for those affected by voice loss. Laronix is an ISO 13485 certified medical device manufacturer, ensuring high-quality standards and safety in its products. The company operates from Brisbane, Australia, and White Plains, New York, and has established partnerships with over 30 hospitals in the U.S., receiving positive feedback from both patients and healthcare providers.
Technologies
Keywords
Company Information
-
Employees 14
-
Founded 2020
-
Total Funding $2000000
Location
Brisbane, Queensland, Australia